EUVIMEDEUVIMED entdecken
Crossref

Ethanol extract of Verbena officinalis alleviates MCAO-induced ischaemic stroke by inhibiting IL17A pathway-regulated neuroinflammation

Wei Zhang, Peng Zhang, Le-Hua Xu, Kai Gao, Juan-Li Zhang, Min-Na Yao, Rui-Li Li, Chao Guo, Jing-Wen Wang, Quan-Xiang Wu

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2023.155237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Wei Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China; Departme…. Hauptthemen laut MEDLINE: Brain Ischemia, Stroke, Verbena, Ischemic Stroke. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The prevention and treatment of ischaemic stroke is a worldwide challenge, and effective clinical treatment strategies are lacking. Studies have demonstrated the efficacy of Verbena officinalis in managing cerebrovascular disorders. However, the neuroprotective bioactive components and mechanisms remain unclear. PURPOSE: To investigate the pharmacological combinatorial components and mechanism underlying the anti-ischemic stroke effect of the ethanol extract of Verbena officinalis (VO Ex). STUDY DESIGN AND METHODS: The components of VO Ex were identified by HPLC. A middle cerebral artery occlusion (MCAO) induced brain injury model was used to assess the therapeutic effect of VO Ex. The activity of the chemical components of VO Ex was evaluated using a primary astrocyte injury model induced by oxygen-glucose deprivation/reperfusion (OGD/R). RNA sequencing was used to reveal the potential targets of VO Ex against cerebral ischemia-reperfusion injury (CIRI), and the results were verified by qRT-PCR and western blotting. The key components and target binding ability were predicted by molecular docking. Finally, the mechanism of combinatorial components was verified by experiments. RESULTS: The HPLC results indicated that the main ingredients of VO Ex were hastatoside, verbenalin, acteoside, luteolin, apigenin and hispidulin. In vivo experiments showed that VO Ex improved MCAO-induced acute cerebral ischemic injury. Transcriptomic data and biological experiments suggested that VO Ex exerted therapeutic effects through IL17A signalling pathways. The in vitro experiments indicated that verbenalin, acteoside, luteolin, apigenin and hispidulin exhibited neuroprotective activities. The novel formula of VALAH, derived from the aforementioned active ingredients, exhibited superior efficacy compared to each individual component. Molecular docking and mechanistic studies have confirmed that VALAH functions in the treatment of ischaemic stroke by suppressing the activation of the IL17A signalling pathway. CONCLUSION: This work is the first to reveal that VO Ex effectively inhibits the IL17A signaling pathway and mitigates neuroinflammation following ischemic stroke. Moreover, we identified the novel formula VALAH as the bioactive combinatorial components for VO Ex. Further research suggests that the activity of VALAH is associated with IL17A-mediated regulation of neuroinflammation. This finding provides new insights into the efficacious components and mechanisms of traditional Chinese medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain IschemiaStrokeVerbenaIschemic StrokeReperfusion InjuryGlucosidesIridoid GlycosidesPolyphenolsHumansInfarction, Middle Cerebral ArteryNeuroinflammatory DiseasesApigeninLuteolinMolecular Docking SimulationInterleukin-17

Stichwörter der Autor:innen

Combinatorial componentsIL17A pathwayIschaemic strokeNeuroinflammationVerbena officinalis

Substanzen

acteosidecornin iridoidApigeninLuteolinIL17A protein, humanInterleukin-17GlucosidesIridoid GlycosidesPolyphenols

Autor:innen und Institutionen

  • State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China; Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, X…
  • State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.
  • Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
  • Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. Electronic address: wangjingwen8021@163.com.
  • State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China. Electronic address: wuqx@lzu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, W., Zhang, P., Xu, L. H., Gao, K., Zhang, J. L., Yao, M. N., Li, R. L., Guo, C., Wang, J. W., & Wu, Q. X. (2024). Ethanol extract of Verbena officinalis alleviates MCAO-induced ischaemic stroke by inhibiting IL17A pathway-regulated neuroinflammation. Phytomedicine. https://doi.org/10.1016/j.phymed.2023.155237

Vancouver

Zhang W, Zhang P, Xu LH, Gao K, Zhang JL, Yao MN, et al. Ethanol extract of Verbena officinalis alleviates MCAO-induced ischaemic stroke by inhibiting IL17A pathway-regulated neuroinflammation. Phytomedicine. 2024. doi:10.1016/j.phymed.2023.155237

BibTeX
@article{Zhang2024,
  author = {Zhang, Wei and Zhang, Peng and Xu, Le-Hua and Gao, Kai and Zhang, Juan-Li and Yao, Min-Na and Li, Rui-Li and Guo, Chao and Wang, Jing-Wen and Wu, Quan-Xiang},
  title = {Ethanol extract of Verbena officinalis alleviates MCAO-induced ischaemic stroke by inhibiting IL17A pathway-regulated neuroinflammation},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2023.155237}
}
Kostenlos starten →